Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial

Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site maintenance or release update without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:38:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:09:17.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' and introduced a Genetic and Rare Diseases Information Center resources section on the study page.
    Difference
    0.2%
    Check dated 2026-04-02T14:45:03.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T20:48:22.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:45:12.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2. The previous funding-status notice and the older Revision: v3.4.1 text have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:32:41.000Z thumbnail image

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.